Showing results (961-970 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|January 11, 2018
Cost-effectiveness of Access to Critical Cerebral Emergency Support Services (ACCESS): a neuro-emergent telemedicine consultation programJustin Whetten, David N van der Goes, Huy Tran, et al.Journal of Medical Economics|May 16, 2022
Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparisonAndrew Menzies-Gow, Jason Steenkamp, Sumeet Singh, et al.Journal of Medical Economics|May 26, 2022
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settingsAndrew Blauvelt, Nianwen Shi, Mwangi J Murage, et al.Journal of Medical Economics|May 20, 2022
Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's diseaseK Ray Chaudhuri, Annette Hand, Fallon Obam, et al.Journal of Medical Economics|June 8, 2021
Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UKStéphane Roze, Maria Ida Buompensiere, Zeynep Ozdemir, et al.Journal of Medical Economics|June 10, 2021
Dose escalation and associated costs in biologic treatment of psoriasis based on real-world dataJerry Bagel, Brad Glick, Jashin J Wu, et al.Journal of Medical Economics|March 4, 2020
The burden of osteoporosis in Saudi Arabia: a scorecard and economic modelRima Aziziyeh, Javier Garcia Perlaza, Najma Saleem, et al.Journal of Medical Economics|March 13, 2020
A ready-to-use liquid glucagon for treatment of severe hypoglycemia demonstrates reduced healthcare payer costs in a budget impact modelBrian Leinwand, Michael Johnsrud, Anh Nguyen, et al.Journal of Medical Economics|September 18, 2020
Alternative payment models and innovation: a case study of US health system adoption of a sacubitril/valsartan to treat acute decompensated heart failureJason Shafrin, Elmar R Aliyev, Michelle Brauer, et al.Journal of Medical Economics|September 24, 2020
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia ALukas Graf, Songkai Yan, Ming-Ching Shen, et al.Pageof 242